Using various administration schedules, the physical dependence produc
ed by dihydroetorphine (DHE) was compared with that of morphine in mic
e. Physical dependence, evaluated by naloxone-precipitated withdrawal
signs, did not develop following daily treatment with DHE (10, 20, 100
and 1000 mu g/kg, i.p. or 30, 100 and 1000 ng/mouse, i.c.v.) for 6 d.
However, 5 repeated injections of DHE (10 mu g/kg, i.p.) at 1 or 2 h
intervals did produce physical dependence and the dependent state disa
ppeared after 2 h. Accordingly, it was demonstrated that a sufficient
degree of antinociceptive activity needed to be maintained, longer tha
n several hours, for the development of physical dependence on DHE and
that the duration of the dependent state was very short. In the singl
e dose suppression test, a single dose of DHE completely suppressed th
e natural withdrawal signs that appeared following abstinence in morph
ine-dependent animals without reappearance of significant withdrawal s
igns, indicating the suitability of DHE as a substitute for morphine.
The characteristic properties of DHE, the extremely potent antinocicep
tive effect and minimal dependence, indicate the separation of the ant
inociceptive effect from dependence, and suggest that it may be possib
le to develop a novel drug which may be safely used in clinical situat
ions.